Updated October 28, 2026

CRO rankings / Firm profile

FBS Consulting logo

FBS Consulting

Last verified 2026-10-27

61
/ 100

Moderate evidence confidence

Australian manufacturers and B2B owners with $2M to $40M of turnover who want Drew Robins in a fractional COO or CRO seat.

Solo Practitioner, High-TouchManufacturing

Homepage screenshot unavailable

This site did not return a usable capture.

Visit FBS Consulting

Also ranked as COO.

Firm details

HQs
Not disclosed

Headquarters is Not published.

Typical buyer
Australian manufacturers and B2B owners with $2M to $40M of turnover who want Drew Robins in a fractional COO or CRO seat.
Verticals
Manufacturing
Specialties
FBS Consulting offers fractional COO, CRO work.

Best fit

  • Drew Robins offers a fractional COO and a fractional CRO to manufacturers and B2B businesses turning over $2M to $40M.
  • The site publishes a 1-day operational diagnostic from $2,000 and an investment from $2,000 to $2,500.
  • The engagement path includes a 90-day fractional COO or CRO step after the diagnostic.

Poor fit

  • The published fee is a diagnostic from $2,000 to $2,500, and the 90-day seat price is Not published.

Pricing

Published rates, firm estimates, and third-party estimates stay in separate rows.

  • The 90-day fractional COO or CRO seat fee is Not published.
Published rate

Fractional COO

$2,000 to $2,500

One-day operational diagnostic on an Australian site.

First-party page, accessed 2026-10-27.

FBS Consulting site

Clients

ClientIndustryWhat they didSource
No named clients published

Where FBS Consulting ranks

Rank is page-relative. See the methodology.

Evidence notes

  • Drew Robins is based on the Gold Coast, and a City, ST headquarters line is Not published.
  • The founding year is Not published, and the $2M to $40M band is company-reported.
  • Score 61 from ratings of 2, 4, 3, 4, and 2 on Track Record, Segment Fit, Pricing Transparency, Responsiveness, and Credentials. Points equal each weight times the rating divided by 5.
Main limitation: The published fee is a diagnostic from $2,000 to $2,500, and the 90-day seat price is Not published.